Pharma market access [infographic]

A 12 step process for preparing a pharma brand for market

There is no 'one' definition of market access – the idea of which varies from company to company; region to region.

But while there may not be consensus on the exact wording – which spans everything from 'stakeholders' to 'accelerate market uptake', 'optimising value' and 'pricing and reimbursement' – most agree that it is not a 'discipline' that can be packaged neatly into a silo.

Inside: Market Access, a new publication from PMLiVE's publishers PMGroup, provides expert thinking on the area and includes a unique market access road map.

The publication, which PME subscribers received earlier this month, also looks at:

• Re-positioning pharma's image for market access success• How to equip market access teams for local challenges• The role of communication and education• The true meaning of market access• UK market access and the NHS• How NICE is collaborating, and exporting its thinking, across Europe and beyond• EU pricing and reimbursement, and reference pricing.